Results 1 to 10 of about 7,758,929 (112)

Advancements and future prospective of DNA barcodes in the herbal drug industry [PDF]

Front Pharmacol, 2022
Ethnopharmacological relevance: The past couple of decades have witnessed the global resurgence of medicinal plants in the field of herbal-based health care.
K. Mahima, Koppala Narayana Sunil Kumar, Kanakarajan Vijayakumari Rakhesh, P. S. Rajeswaran, Ashutosh Sharma, R. Sathishkumar   +5 more
semanticscholar   +2 more sources

Exposing drug industry funding of UK patient organisations

BMJ, 2019
Drug company payment disclosures have limited transparency, but Piotr Ozieranski and colleagues find that they are increasing in value and are targeted at select patient ...
P. Ozieranski, Emily Rickard, S. Mulinari   +2 more
semanticscholar   +3 more sources

Industry-Scale Orchestrated Federated Learning for Drug Discovery [PDF]

AAAI Conference on Artificial Intelligence, 2022
To apply federated learning to drug discovery we developed a novel platform in the context of European Innovative Medicines Initiative (IMI) project MELLODDY (grant n°831472), which was comprised of 10 pharmaceutical companies, academic research labs ...
M. Oldenhof, G. Ács, Balázs Pejó, A. Schuffenhauer, Nicholas Holway, Noé Sturm, Arne Dieckmann, Oliver Fortmeier, Eric Boniface, Cl'ement Mayer, Arnaud Gohier, Peter Schmidtke, Ritsuya Niwayama, D. Kopecky, Lewis H. Mervin, P. C. Rathi, Lukas Friedrich, András Formanek, Peter Antal, J. Rahaman, Adam Zalewski, Ezron Oluoch, Manuel Stößel, Michal Vanco, David Endico, Fabien Gelus, Thaïs de Boisfossé, Adrien Darbier, Ashley Nicollet, Matthieu Blottière, Maria Teleńczuk, Van Tien Nguyen, Thibaud Martinez, Camille Boillet, K. Moutet, Alexandre Picosson, Aur'elien Gasser, I. Djafar, Adam Arany, J. Simm, Y. Moreau, O. Engkvist, H. Ceulemans, Camille Marini, M. Galtier   +44 more
semanticscholar   +1 more source

Natural products in drug discovery: advances and opportunities

Nature reviews. Drug discovery, 2021
Natural products and their structural analogues have historically made a major contribution to pharmacotherapy, especially for cancer and infectious diseases.
A. Atanasov, S. Zotchev, V. Dirsch, Ilkay Erdogan Maciej Judith M. Davide Wolfram Rudolf Edw Orhan Banach Rollinger Barreca Weckwerth Bauer Bay, I. Orhan, M. Banach, J. Rollinger, D. Barreca, W. Weckwerth, R. Bauer, E. Bayer, M. Majeed, A. Bishayee, V. Bochkov, G. Bonn, N. Braidy, F. Bucar, A. Cifuentes, G. D’Onofrio, Michael A. Bodkin, M. Diederich, A. Dinkova-Kostova, T. Efferth, Khalid El Bairi, N. Arkells, Tai-Ping Fan, B. Fiebich, M. Freissmuth, M. Georgiev, S. Gibbons, K. Godfrey, Christian W. Gruber, J. Heer, Lukas A. Huber, E. Ibáñez, A. Kijjoa, A. Kiss, Aiping Lu, F. A. Macias, Mark J. S. Miller, A. Mocan, Rolf Müller, F. Nicoletti, George Perry, V. Pittalà, L. Rastrelli, M. Ristow, G. Russo, A. S. Silva, D. Schuster, H. Sheridan, K. Skalicka‐Woźniak, L. Skaltsounis, E. Sobarzo-Sánchez, D. Bredt, H. Stuppner, A. Sureda, N. Tzvetkov, R. A. Vacca, Bharat B. Aggarwal, M. Battino, Francesca Giampieri, M. Wink, J. Wolfender, Jianbo Xiao, A. Yeung, G. Lizard, M. Popp, Michael Heinrich, I. Berindan‐Neagoe, M. Stadler, M. Daglia, R. Verpoorte, C. Supuran   +73 more
semanticscholar   +1 more source

The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules

Molecules, 2023
While 2021 ended with the world engulfed in the COVID-19 Omicron wave, 2022 has ended in almost all countries, except China, with COVID-19 being likened to the flu. In this context, the U.S.
B. G. de la Torre, F. Albericio
semanticscholar   +1 more source

Behind the French controversy over the medical treatment of Covid-19: The role of the drug industry

Journal of Sociology, 2020
This article explores the stakes of the very intense controversy that has developed in France around the medical treatment of Covid-19 (which finds some parallels in the United States of America).
L. Mucchielli
semanticscholar   +1 more source

The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules

Molecules, 2021
Although the pharmaceutical industry will remember 2020 as the year of COVID-19, it is important to highlight that this year has been the second-best—together with 1996—in terms of the number of drugs accepted by the US Food and Drug Administration (FDA).
B. G. Torre, F. Albericio
semanticscholar   +1 more source

Human organs-on-chips for disease modelling, drug development and personalized medicine

Nature reviews genetics, 2022
The failure of animal models to predict therapeutic responses in humans is a major problem that also brings into question their use for basic research.
D. Ingber
semanticscholar   +1 more source

Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems

Polymers, 2023
In the last four decades, nanotechnology has gained momentum with no sign of slowing down. The application of inventions or products from nanotechnology has revolutionised all aspects of everyday life ranging from medical applications to its impact on ...
Azeez Yusuf, Awatif R. Z. Almotairy, Hanan A Henidi, Ohoud Y. Alshehri, M. Aldughaim   +4 more
semanticscholar   +1 more source

A Blockchain and Machine Learning-Based Drug Supply Chain Management and Recommendation System for Smart Pharmaceutical Industry

Electronics, 2020
From the last decade, pharmaceutical companies are facing difficulties in tracking their products during the supply chain process, allowing the counterfeiters to add their fake medicines into the market.
Khizar Abbas, Muhammad Afaq, Talha Ahmed Khan, Wang-Cheol Song   +3 more
semanticscholar   +1 more source